Thoughts on combination carfilzomib & daratumumab in revlimid-refractory multiple myeloma

Thoughts on combination carfilzomib & daratumumab in revlimid-refractory multiple myeloma

User Photo
obr

2 years
101 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Noa Biran, MD, discusses her thoughts on the promising combination of carfilzomib and daratumumab in revlimid-refractory multiple myeloma patients at the 2018 Annual Meeting.
Up Next Autoplay